[EN] 2- (QUINOXALIN-5-YLSULFONYLAMINO) -BENZAMIDE COMPOUNDS AS CCK2 MODULATORS<br/>[FR] COMPOSES DE 2- (QUINOXALINE-5-YLSULFONYLAMINO) -BENZAMIDE UTILISES EN TANT QUE MODULATEUR DU RECEPTEUR CCK2
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2005016896A1
公开(公告)日:2005-02-24
Certain amidophenyl-sulfonylamino-quinoxaline compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.